Navigation Links
HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City

FRAMINGHAM, Mass. and SYDNEY, Nov. 25 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator and provider of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that it is scheduled to make an investor presentation at the 21st Annual Piper Jaffray Health Care Conference at 8:00 am EST on Wednesday, December 2, 2009. The conference is being held at the New York Palace Hotel, December 1-2.

A live webcast of the Company's presentation at the conference will be available via a link provided at An archived replay of the presentation will also be available shortly after the presentation time for a period of 90 days.

About HeartWare International

HeartWare International develops and manufactures miniaturized implantable heart pumps, or left ventricular assist devices, to treat Class IIIb and Class IV patients suffering from advanced heart failure. The HeartWare® Ventricular Assist System features the HVAD(TM) pump, a small full-output circulatory support device (up to 10L/min flow) designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices. HeartWare has received CE Marking for the HeartWare® Ventricular Assist System in the European Union. The device is currently the subject of a 150-patient clinical trial in the United States for a Bridge-to-Transplant indication.

For further information:
U.S. Investor Relations
Matt Clawson
Allen & Caron Inc
Tel: +1 949 474 4300

SOURCE HeartWare International, Inc.

Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartWare International Reports Third Quarter Revenues of $7.5 Million
2. U.S. FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U.S. Bridge-to-Transplant Clinical Trial
3. HeartWare International Clinical Trial Shows 90% Survival at 180 Days
4. Presentation of HeartWare Clinical Results
5. Chindex International to Present at Piper Jaffray Health Care Conference
6. Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference
7. Thoratec Presentation at Piper Jaffray Conference to be Webcast
8. Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference
9. Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting
10. Echo Therapeutics to Present at the New York Society of Security Analysts 13th Annual Biotech and Specialty Pharmaceuticals Conference
11. Neurocrine Biosciences to Present at the 21st Annual Piper Jaffray Health Care Conference
Post Your Comments:
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: ... of chronic pain, announced today that the company will present ... held December 1-3 at the Luxe Sunset Boulevard Hotel in ... , CEO of Relmada Therapeutics, will present on Thursday, December ... . Please register at least 10 minutes ...
(Date:12/1/2015)... ANGELES , Dec. 1, 2015 CytRx ... development company specializing in oncology, today announced that it ... the company,s pivotal global Phase 3 clinical trial of ... (STS). Enrollment was originally estimated to be completed in Q1 ... being conducted under a Special Protocol Assessment from the ...
(Date:12/1/2015)... CHESTERBROOK, Pa. , Dec. 1, 2015 /PRNewswire/ ... leader, announced the launch of CareFront, a first-of-its-kind ... of patients diagnosed with cancer. Designed to be ... newly diagnosed cancer patients with resources for their ... costs. The program also offers tools to help ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 2015 , ... Dr. Paul Vitenas, one of the top cosmetic surgeons ... magazine as the Best Single Physician Practice in the nation. Dr. Vitenas and his ... honored by the industry publication. , Dr. Vitenas said he was very honored ...
(Date:12/1/2015)... ... December 01, 2015 , ... Growth in medical payments per workers’ compensation claim ... of hospital and nonhospital care, according to a recent study by the Workers Compensation ... Edition , found medical payments per claim with more than seven days of lost ...
(Date:12/1/2015)... York, NY (PRWEB) , ... December 01, 2015 ... ... epidemic in the 1980s we have seen vast improvements in scientific research and ... made significant strides, providing increased hope and relief to those affected by HIV/AIDS. ...
(Date:12/1/2015)... ... December 01, 2015 , ... It’s official: Tattoo taboo is ... a number even greater among Millennials (a whopping one in three aged 18 to ... people who are dissatisfied with their ink. In fact, RealSelf , the world’s ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... amputations in the United States. Podiatrists are well aware that psychology-based patient non-compliance ... behaviors) are often catastrophic contributors to diseases of the diabetic foot. The ...
Breaking Medicine News(10 mins):